- Home
- SQFT vs CDIO Comparison
SQFT vs CDIO Comparison
Compare SQFT & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- CDIO
- Stock Information
- Founded
- SQFT 1999
- CDIO 2017
- Country
- SQFT United States
- CDIO United States
- Employees
- SQFT 15
- CDIO N/A
- Industry
- SQFT Real Estate Investment Trusts
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SQFT Real Estate
- CDIO Health Care
- Exchange
- SQFT Nasdaq
- CDIO Nasdaq
- Market Cap
- SQFT 7.7M
- CDIO 6.4M
- IPO Year
- SQFT 2020
- CDIO N/A
- Fundamental
- Price
- SQFT $5.11
- CDIO $3.45
- Analyst Decision
- SQFT
- CDIO Buy
- Analyst Count
- SQFT 0
- CDIO 1
- Target Price
- SQFT N/A
- CDIO $60.00
- AVG Volume (30 Days)
- SQFT 2.7M
- CDIO 42.0K
- Earning Date
- SQFT 08-18-2025
- CDIO 08-19-2025
- Dividend Yield
- SQFT N/A
- CDIO N/A
- EPS Growth
- SQFT N/A
- CDIO N/A
- EPS
- SQFT N/A
- CDIO N/A
- Revenue
- SQFT $18,260,398.00
- CDIO $19,902.00
- Revenue This Year
- SQFT $23.63
- CDIO $1,434.82
- Revenue Next Year
- SQFT N/A
- CDIO $4,661.91
- P/E Ratio
- SQFT N/A
- CDIO N/A
- Revenue Growth
- SQFT N/A
- CDIO N/A
- 52 Week Low
- SQFT $4.19
- CDIO $3.22
- 52 Week High
- SQFT $23.00
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- SQFT 41.96
- CDIO 34.94
- Support Level
- SQFT $5.46
- CDIO $3.81
- Resistance Level
- SQFT $6.77
- CDIO $4.12
- Average True Range (ATR)
- SQFT 0.64
- CDIO 0.36
- MACD
- SQFT -0.27
- CDIO -0.05
- Stochastic Oscillator
- SQFT 7.14
- CDIO 5.88
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.